NLRP1 and atopic eczema: Our findings were also consistent with the association of NLRP1 overexpression or gain-of-function mutations with the prevalence of skin diseases such as psoriasis, vitiligo, atopic dermatitis or hyperkeratosis [36] where senescence had been widely described [37, 38].